CavKAHYBRID– between hard spheres and Gaussians
© Koelling and Baumann; licensee BioMed Central Ltd. 2012
Published: 1 May 2012
Three dimensional pharmacophores and pharmacophore searches are well established in virtual screening and have been applied successfully in many prospective and retrospective drug discovery campaigns . While the pharmacophore concept offers an easy and abstract understanding of molecular properties, plenty of user intervention is required to define feasible models.
Recently, Silicos NV provided their freely available ligand centric pharmacophore method Pharao . Pharao employs three dimensional Gaussians to reflect a molecule’s pharmacophoric properties, in contrast to most methods which use conventional hard sphere models. Gaussian models show the advantage that they require far less user intervention for model creation.
Here we present a hybrid model that utilizes the Gaussian pharmacophore representation of Pharao to be adapted and used in CavKA (Cavity Knowledge Acceleration), our own in-house strategy for structure based pharmacophore generation. CavKA interprets ligand-receptor complexes and detects interaction between ligand and binding site in order derive pharmacophore models automatically. In addition Grid  Molecular Interaction Fields (MIFs) can be used to weight and prioritize interacting features. By combining the smooth nature of Gaussian pharmacophores in the binding site and representing the receptor by a hard sphere excluded volume, structure based pharmacophores can be created without any user intervention.
The performance of CavKAHYBRID is compared to the purely ligand centric approach Pharao in a retrospective virtual screening on the Field Screen  dataset. It is the objective of this study to analyse in how far protein information can be used to improve screening results while no user intervention is required for model building. Furthermore the effect of a Gaussian representation of the excluded volume in CavKAHYBRID is analysed.
- Leach AR, Gillet VJ, Lewis RA, Tailor R: Three-Dimensional Pharmacophore Methods in Drug Discovery. J Med Chem. 2010, 53: 539-558. 10.1021/jm900817u.View ArticleGoogle Scholar
- Pharao 3.0.3, Silicos NV. [http://www.silicos.be]
- Grid 22a, Molecular Discovery. [http://www.moldiscovery.com]
- Cheeseright TJ, Mackey MD, Melville JM, Vinter JG: FieldScreen: Virtual Screening Using Molecular Fields. Application to the DUD Data Set. J Chem Inf Model. 2008, 48: 2108-2117. 10.1021/ci800110p.View ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.